(Q43170220)

15 November 2017

title

Arginine vasopressin prevents against Abeta(25-35)-induced impairment of spatial learning and memory in rats (English)

1 reference

15 November 2017

0 references

Yan-Fang Pan

1

1 reference

15 November 2017

Xiao-Rong Chen

2

1 reference

15 November 2017

Mei-Na Wu

3

1 reference

15 November 2017

Cun-Gen Ma

4

1 reference

15 November 2017

Jin-Shun Qi

5

1 reference

15 November 2017

publication date

6 February 2010

1 reference

15 November 2017

published in

Hormones and Behaviour

1 reference

15 November 2017

volume

57

1 reference

15 November 2017

issue

4-5

1 reference

15 November 2017

page(s)

448-454

1 reference

A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Abeta(25-35).

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Neuromodulation: associative and nonlinear adaptation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

The Ca2+ influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Vasopressin-induced neurotrophism in cultured neurons of the cerebral cortex: dependency on calcium signaling and protein kinase C activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Anatomy and function of extrahypothalamic vasopressin systems in the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Vasopressin and memory. I. The vasopressin analogue AVP4-9 enhances working memory as well as reference memory in the radial arm maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Vasopressin and memory. II. Lesions to the hippocampus block the memory enhancing effects of AVP4-9 in the radial maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

V1a receptor knockout mice exhibit impairment of spatial memory in an eight-arm radial maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Vasopressin administration via microdialysis into the septum interferes with the acquisition of spatial memory in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Behavioral consequences of intracerebral vasopressin and oxytocin: focus on learning and memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Differential modulation of lateral septal vasopressin receptor blockade in spatial learning, social recognition, and anxiety-related behaviors in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Activation of vasopressinergic and oxytocinergic neurons during aging in the Wistar rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Effect of active fragments of arginine-vasopressin on the disturbance of spatial cognition in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Effect of beta-amyloid block of the fast-inactivating K+ channel on intracellular Ca2+ and excitability in a modeled neuron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

V1a- and V2-type vasopressin receptors mediate vasopressin-induced Ca2+ responses in isolated rat supraoptic neurones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

The effect of chronic vs. acute injection of vasopressin on animal learning and memory.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

No. 302, a newly synthesized [pGlu4,Cyt6]AVP(4-9) analogue, prevents the disruption of avoidance behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Activation of vasopressin neurons in the human supraoptic and paraventricular nucleus in senescence and senile dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Neurohypophyseal peptides in aging and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Stress hormones enhance retrieval of fear conditioning acquired either one day or many months before

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Facilitation of avoidance behavior by vasopressin fragments microinjected into limbic-midbrain structures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Abeta-42 deposition precedes other changes in PS-1 Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Pathways towards and away from Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Vasopressin in Alzheimer's disease: a study of postmortem brain concentrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Effect of changes in the intrahippocampal vasopressin on memory retrieval and relearning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

[Arg8]-vasopressin-induced increase in intracellular Ca2+ concentration in cultured rat hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Ameliorative effect of vasopressin-(4-9) through vasopressin V(1A) receptor on scopolamine-induced impairments of rat spatial memory in the eight-arm radial maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Ameliorative effect of NC-1900, a new AVP4-9 analog, through vasopressin V1A receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Differential susceptibility following beta-amyloid peptide-(1-40) administration in C57BL/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Amyloid beta-protein fragment 31-35 forms ion channels in membrane patches excised from rat hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Alzheimer's disease: genes, proteins, and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Studies of the effects of fragment (25-35) of beta-amyloid peptide on the behavior of rats in a radial maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

No vasopressin cell loss in the human hypothalamus in aging and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25-35 i.c.v.-injected mice: involvement of dopaminergic systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Amyloid beta-protein fragment 31-35 suppresses long-term potentiation in hippocampal CA1 region of rats in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

Facilitation of AVP(4-8) on gene expression of BDNF and NGF in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2010.01.015

10.1016/J.YHBEH.2010.01.015

7 January 2021

Identifiers

DOI

1 reference

15 November 2017

1 reference